Dr. Maria E. Theodorou, MD

Dr. Theodorou practices at Methodist Hospitals - Northlake in Gary, Indiana, part of The Methodist Hospitals.

Dr. Theodorou's NPI, 1427390244, was assigned on March 19, 2013. Dr. Theodorou graduated from Loyola University of Chicago, Stritch School of Medicine in 2013. Dr. Theodorou holds Illinois license 036139541.

Dr. Theodorou's primary practice is Methodist Hospitals - Northlake, at 600 Grant St, Gary, IN 46402 in Lake County. The practice phone is (219) 886-4000.

Dr. Theodorou's primary practice is Methodist Hospitals - Northlake in Gary, Indiana, part of The Methodist Hospitals. Dr. Theodorou is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Theodorou to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Theodorou practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Theodorou's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Theodorou is licensed in Illinois.

CMS data shows 115 Medicare services from Dr. Theodorou across 3 procedure codes in 2024, for 55 Medicare patients. Medicare paid $9,469 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 55 Medicare patients who saw Dr. Theodorou in 2024. The largest group is under 65, with 16 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 3.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Theodorou's median patient age at 70, with 51% women.

In 2024, Dr. Theodorou wrote 442 Medicare Part D claims for 17 patients. 82% of them were for generic drugs. CMS names the drug for 136 of them, across 8 drugs with 11 or more claims each, at $4,952 in total drug cost. In 2023, CMS named 46 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Theodorou for performance year 2024, reported through an alternative payment model (APM). Dr. Theodorou accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Theodorou, published from 2020 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Endocarditis, Bacterial and Gram-Positive Bacterial Infections. Dr. Theodorou's most frequent co-authors are Kelly E. R. Bachta, MD, PhD, Susan E. Cohn, MD and Phillip Pasquale Santoiemma, MD.

CMS Open Payments shows 1 general payment to Dr. Theodorou from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $140.

Dr. Theodorou graduated from Loyola University of Chicago, Stritch School of Medicine in 2013.